Home » Topics » Regulatory

Regulatory
RSS

FDA approves Ibrance for new metastatic breast cancer indication

Feb. 24, 2016

FDA approves Halaven in new indication

Jan. 29, 2016

FDA approves Merck & Co.'s Zepatier for HCV infection

Jan. 29, 2016

Expanded FDA approvals for Opdivo + Yervoy and single-agent Opdivo in melanoma

Jan. 25, 2016

UCB's Briviact approved in E.U. as adjunctive treatment for partial-onset seizures

Jan. 22, 2016

FDA approves Neulasta to treat radiation sickness

Jan. 21, 2016

SK Chemicals' SKY Cellflu Quadrivalent approved in South Korea

Dec. 29, 2015

FDA approves AstraZeneca's Zurampic for hyperuricemia in gout

Dec. 23, 2015

FDA approves Uptravi for pulmonary arterial hypertension

Dec. 22, 2015

FDA approves Keytruda for first-line treatment of unresectable or metastatic melanoma

Dec. 21, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...